FindTrial
Sign In

Efficacy of prophylactic intravesical chemotherapy for bladder tumor recurrence after nephron spring surgery for primary upper tract urothelial carcinoma

Efficacy of prophylactic intravesical chemotherapy for bladder tumor recurrence after nephron spring surgery for primary upper tract urothelial carcinoma

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOR-17010346
Enrollment
Unknown
Registered
2017-01-06
Start date
2017-01-09
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

UTUC

Interventions

Control:no
intravesical instillation:Pirarubicin 40mg after NSS

Sponsors

Department of Urology, Beijing Hospital of the Ministry of Health
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. unilateral UTUC; 2. Nephron spring surgery( PNCL, URS,ureterectomy,ureteral-bladder reimplantation; 3. patholgy was urothelial carcinoma; 4. Inclusion should follow all above conditions.

Exclusion criteria

Exclusion criteria: 1. Concomitant with bladder cancer; 2. Previous urothelial carcinoma history; 3. Preoperatively receiving neoadjuvant chemotherapy; 4. Renal allograft recipients.

Design outcomes

Primary

MeasureTime frame
Bladder cancer recurrence;—

Secondary

MeasureTime frame
durg adverse effect;tumor progression;Local recurrence;survival;—

Countries

China

Contacts

Public ContactJianye Wang

Department of Urology, Beijing Hospital of the Ministry of Health

wangjy@bjhmoh.com.cn+86 010 85136272

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026